Published in Am J Epidemiol on April 23, 2010
Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol (2012) 2.48
Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data. J Am Med Inform Assoc (2012) 1.55
Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis. Hum Mol Genet (2016) 0.94
Risk of site-specific cancer in incident venous thromboembolism: a population-based study. Thromb Res (2014) 0.94
Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The Longitudinal Study of Thromboembolism Etiology (LITE). Thromb Haemost (2011) 0.84
Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study. J Am Heart Assoc (2014) 0.84
Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study. Eur J Epidemiol (2013) 0.83
Venous thromboembolism and subsequent permanent work-related disability. J Thromb Haemost (2016) 0.82
Shorter height is related to lower cardiovascular disease risk - a narrative review. Indian Heart J (2012) 0.78
Adult height, nutrition, and population health. Nutr Rev (2016) 0.78
The increased risk of venous thromboembolism by advancing age cannot be attributed to the higher incidence of cancer in the elderly: the Tromsø study. Eur J Epidemiol (2014) 0.78
Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology. Thromb Res (2016) 0.77
Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study. Thromb Res (2016) 0.77
Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study. J Am Heart Assoc (2016) 0.75
Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study. PLoS One (2016) 0.75
Neutrophil to lymphocyte ratio and future risk of venous thromboembolism and mortality: the Tromsø Study. Haematologica (2016) 0.75
Taller women are at greater risk of recurrent venous thromboembolism: the Iowa Women's Health Study. Am J Hematol (2012) 0.75
The effects of obesity on venous thromboembolism: A review. Open J Prev Med (2012) 0.75
Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis. J Thromb Haemost (2017) 0.75
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med (2006) 9.53
Lung cancer susceptibility locus at 5p15.33. Nat Genet (2008) 5.99
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet (2009) 4.11
Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA (2012) 3.67
Fine mapping of five loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability. PLoS Genet (2011) 3.56
Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet (2010) 3.34
Cohort profile: the Tromso Study. Int J Epidemiol (2011) 3.29
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83
Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA (2009) 2.66
Effect of caudal epidural steroid or saline injection in chronic lumbar radiculopathy: multicentre, blinded, randomised controlled trial. BMJ (2011) 2.48
Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol (2011) 2.25
Echocardiographic screening of the general population and long-term survival: a randomized clinical study. JAMA Intern Med (2013) 2.13
Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Tromsø Study. Stroke (2011) 2.07
Impact of incident venous thromboembolism on risk of arterial thrombotic diseases. Circulation (2013) 2.04
[How are patients with acute coronary syndromes treated in Norwegian hospitals?]. Tidsskr Nor Laegeforen (2005) 2.03
Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke (2010) 1.97
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst (2004) 1.93
Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø Study. Stroke (2007) 1.93
Longitudinal reference ranges for estimated fetal weight. Acta Obstet Gynecol Scand (2006) 1.83
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet (2012) 1.77
Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep (2009) 1.76
Cohort profile: cohort of Norway (CONOR). Int J Epidemiol (2007) 1.72
A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68
Does a variation in self-reported physical activity reflect variation in objectively measured physical activity, resting heart rate, and physical fitness? Results from the Tromso study. Scand J Public Health (2010) 1.67
Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study. Nutr Metab Cardiovasc Dis (2007) 1.62
Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001. Eur Heart J (2005) 1.61
Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation (2012) 1.59
Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Atherosclerosis (2008) 1.59
Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained. PLoS Genet (2013) 1.57
Ambulatory blood pressure is associated with measured glomerular filtration rate in the general middle-aged population. J Hypertens (2012) 1.48
Creatine kinase activity and blood pressure in a normal population: the Tromsø study. J Hypertens (2011) 1.47
Seasonal variation in incidence of acute myocardial infarction in a sub-Arctic population: the Tromsø Study 1974-2004. Eur J Cardiovasc Prev Rehabil (2011) 1.45
Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int (2010) 1.42
Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels. Thromb Haemost (2009) 1.42
Osteoprotegerin is associated with hip fracture incidence: the Tromso Study. Int J Epidemiol (2012) 1.40
[A 53-year-old man with headache and concentration difficulties]. Tidsskr Nor Laegeforen (2005) 1.39
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol (2010) 1.36
Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy. Am J Obstet Gynecol (2005) 1.32
Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant (2008) 1.30
Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. Eur J Cardiovasc Prev Rehabil (2009) 1.28
Albuminuria as risk factor for initiation and progression of carotid atherosclerosis in non-diabetic persons: the Tromsø Study. Eur Heart J (2006) 1.27
Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study. PLoS One (2012) 1.23
Evaluation of the medical student research programme in Norwegian medical schools. A survey of students and supervisors. BMC Med Educ (2009) 1.21
Impaired fasting glucose is associated with renal hyperfiltration in the general population. Diabetes Care (2011) 1.20
Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study. Eur J Endocrinol (2009) 1.19
Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur J Endocrinol (2010) 1.18
The sixth survey of the Tromso Study (Tromso 6) in 2007-08: collaborative research in the interface between clinical medicine and epidemiology: study objectives, design, data collection procedures, and attendance in a multipurpose population-based health survey. Scand J Public Health (2013) 1.16
Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol (2010) 1.16
Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromsø Study. Stroke (2005) 1.15
Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis. BMC Med (2012) 1.15
No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol (2002) 1.12
The clinical effectiveness of web-based cognitive behavioral therapy with face-to-face therapist support for depressed primary care patients: randomized controlled trial. J Med Internet Res (2013) 1.11
Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. The Tromso Study. Eur J Prev Cardiol (2011) 1.11
Incidence of and risk factors for type-2 diabetes in a general population: the Tromsø Study. Scand J Public Health (2010) 1.10
Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study. Arterioscler Thromb Vasc Biol (2011) 1.10
Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study. Stroke (2012) 1.09
Effective filtering strategies to improve data quality from population-based whole exome sequencing studies. BMC Bioinformatics (2014) 1.06
The Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) project--design, population and data harmonization of a large-scale, international study. Eur J Epidemiol (2014) 1.06
Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromsø study. Circulation (2005) 1.04
Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles. Thromb Res (2012) 1.02
The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study. Cardiovasc Diabetol (2012) 1.02
The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway. Eur J Cardiovasc Prev Rehabil (2007) 1.02